Tilal Elsaman

Mr. Tilal Elsaman


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2019 in Current Pharmacology Reports
Verified
Journal Article
Closed access
PDF file
MAMosab Yahya Al-Nour
Mosab Yahya Al-Nour
MIMusab Mohamed Ibrahim
Musab Mohamed Ibrahim
TETilal Elsaman
Tilal Elsaman

13 September 2011 in Molecules
Verified
Journal Article
Open access
PDF file
Tarek Aboul-FadlTarek Aboul-Fadl
Tarek Aboul-Fadl
HAHatem Abdel-Aziz
Hatem Abdel-Aziz
MAMohammed Abdel-Hamid
Mohammed Abdel-Hamid
TETilal Elsaman
Tilal Elsaman
JTJane Thanassi
Jane Thanassi
MPMichael J. Pucci
Michael J. Pucci
In the present study a series of Schiff bases of indoline-2,3-dione were synthesized and investigated for their Mtb gyrase inhibitory activity. Promising inhibitory activity was demonstrated with some of these derivatives, which exhibited IC50 values ranging from 50–157 mM. The orientation and the ligand-receptor interactions of such molecules within the Mtb DNA gyrase A subunit active site were investigated applying a multi-step docking protocol using Molecular Operating Environment (MOE) and Autodock4 docking software. The results revealed the importance of the isatin moiety and the connecting side chain for strong interactions with the enzyme active site. Among the tested compounds the terminal aromatic ring benzofuran showed the best activity. Promising new leads for developing a novel class of Mtb gyrase inhibitors were obtained from Schiff bases of indoline-2,3-dione.

1 December 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HAHatem Abdel-Aziz
Hatem Abdel-Aziz
TETilal Elsaman
Tilal Elsaman
AAAbdullah Al-Dhfyan
Abdullah Al-Dhfyan
MAMohamad Attia
Mohamad Attia
KAKhalid A. Al-Rashood
Khalid A. Al-Rashood
AAAbdul-Rahman M. Al-Obaid
Abdul-Rahman M. Al-Obaid

1 July 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
TETilal Elsaman
Tilal Elsaman
MMMalik Suliman Mohamed
Malik Suliman Mohamed
MMMagdi A. Mohamed
Magdi A. Mohamed

3 February 2019 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
MAMazin A. S. Abdelwahid
Mazin A. S. Abdelwahid
TETilal Elsaman
Tilal Elsaman
MMMalik Suliman Mohamed
Malik Suliman Mohamed
SLSara A. Latif
Sara A. Latif
MMMoawia M. Mukhtar
Moawia M. Mukhtar
MMMagdi A. Mohamed
Magdi A. Mohamed
Leishmaniasis is a fatal neglected parasitic disease caused by protozoa of the genusLeishmaniaand transmitted to humans by different species ofphlebotominesandflies. The disease incidence continues to increase due to lack of vaccines and prophylactic drugs. Drugs commonly used for the treatment are frequently toxic and highly expensive. The problem of these drugs is further complicated by the development of resistance. Thus, there is an urgent need to develop new antileishmanial drug candidates. The aim of this study was to synthesize certain quinoline-4-carboxylic acids, confirm their chemical structures, and evaluate their antileishmanial activity. Pfitzinger reaction was employed to synthesize fifteen quinoline-4-carboxylic acids (Q1-Q15) by reacting equimolar mixtures of isatin derivatives and appropriateα-methyl ketone. The products were purified, and their respective chemical structures were deduced using various spectral tools (IR, MS,1H NMR, and13C NMR). Then, they were investigated againstL. donovanipromastigote (clinical isolate) in different concentration levels (200 μg/mL to 1.56 μg/mL) against sodium stibogluconate and amphotericin B as positive controls. The IC50for each compound was determined and manipulated statistically. Among these compounds,Q1(2-methylquinoline-4-carboxylic acid) was found to be the most active in terms of IC50.